Enantioselective Hydrogenations
5391 5400
NMR (CDCl3,121 MHz): d À15.5; HRMS: m/z: calcd for C30H29NOP:
0.043 mmol,43%) was produced as
a
yellow solid. M.p. 81 84 8C
450.19868 [MH] ; found: 450.19874.
(decomp); [a]2D4 À15.28 (c 1.7,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 7.76 7.29 (m,20H),7.21 7.14 (m,2H),4.88 (m,1H),4.39 4.33 (m,
2H),4.26 (t, J 9 Hz,1H),4.05 (dd, J 9,3 Hz,1H),3.99 (m,1H),2.94
(m,1H),2.86 2.68 (m,2H),2.49 (m,1H),2.40 (s,1H),2.37 2.33 (m,2H),
2.19 2.05 (m,2H),1.98 1.96 (m,3H),1.86 (s,1H),1.79 (s,5H),1.72 (s,
(S)-2-Diphenylmethyl-4-[(bis(2-methylphenyl)phosphino)ethyl]oxazoline
(1g): Rf 0.69 (ethyl acetate/hexane 3:7 v/v); [a]2D4 À70.6 (c 5.7,
CHCl3); 1H NMR (CDCl3,300 MHz): d 7.80 7.30 (m,8H),7.29 7.15
(m,10H),5.17 (s,1H),4.40 4.31 (m,2H),4.16 (m,1H),3.96 (dd,
6 Hz,1H),2.46 (s,6H),2.14 2.10 (m,1H),2.02 (m,1H),1.82 1.74 (m,
J 7,
2H),1.66 1.62 (m,1H),1.57 1.38 (m,5H),1.31 1.29 (m,2H);
31P NMR
(CDCl3,121 MHz): d 6.9; elemental analysis calcd (%) for C67H56BF24Ir-
2H); 13C NMR (CDCl3,75 MHz): d 167.4,142.5 141.9,139.3,136.4,
NOP: C 50.90,H 3.57,N 0.89; found: C 51.64,H 3.72,N 0.84.
131.0,129.9,128.6 128.4,127.1,126.0,72.2,66.7 (d,
JC,P 13.5 Hz),50.1,
32.9 (d, JC,P 18 Hz),22.6 (d, JC,P 11.5 Hz),21.1 (d, JC,P 21 Hz); 31P
Complex 2e: This compound was prepared by the same method used for
compound 2b,but beginning with 1e (75 mg,0.142 mmol) and chloro-(1,5-
cyclooctadiene)iridium(i) dimer (48 mg,0.071 mmol). Complex 2e (94 mg,
0.055 mmol,39%) was produced as a dark yellow solid. M.p. 177 179 8C
(decomp); [a]2D4 À58.28 (c 2.3,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 7.76 7.17 (m,32H),6.99 6.89 (m,5H),4.95 (m,1H),4.75 (m,1H),
4.58 (t, J 9 Hz,1H),4.41 (dd, J 10,4 Hz,1H),3.43 (m,2H),2.83 (m,
1H),2.66 2.53 (m,2H),2.43 2.36 (m,1H),2.24 2.13 (m,2H),2.01 (m,
NMR (CDCl3,121 MHz): d À37.3; LSIMS: m/z: calcd for C32H33NOP:
478 [MH] ; found: 478.
(S)-2-(1,1-Diphenyl)ethyl-4-[(bis(2-methylphenyl)phosphino)ethyl]oxazo-
line (1h): Rf 0.82 (ethyl acetate/hexane 3:7 v/v); [a]2D4 À68.7 (c 9.0,
1
CHCl3); H NMR (CDCl3,300 MHz): d 7.40 7.20 (m,18H),4.39 4.30
(m,2H),3.98 (m,1H),2.47 (s,6H),2.15 2.13 (m,1H),2.10 (s,3H),2.10
2.03 (m,1H),1.82 1.77 (m,2H); 13C NMR (CDCl3,75 MHz): d 170.7,
144.8,142.5 141.9,136.8 136.4,131.1,129.9,128.7 128.4,127.9,126.6,
126.0,72.2,66.6 (d, JC-,P 13.5 Hz),50.3,31.9 (d, JC,P 18 Hz),28.4,22.5 (d,
JC,P 11.5 Hz),21.2 (d, JC,P 21 Hz); 31P NMR (CDCl3,121 MHz): d
1H),1.87 (m,1H),1.74 (m,1H),1.28 1.17 (m,2H),1.15 1.04 (m,2H);
31P
NMR (CDCl3,121 MHz): d À1.5; elemental analysis calcd (%) for
C76H56BF24IrNOP: C 54.04,H 3.34,N 0.83; found: C 54.06,H 3.39,N 0.79.
À37.3; LSIMS: m/z: calcd for C33H35NOP: 490 [MH] ; found: 490.
Complex 2 f: This compound was prepared by the same method used for
compound 2b,but beginning with 1 f (40 mg,0.089 mmol) and chloro-(15, -
cyclooctadiene)iridium(i) dimer (30 mg,0.044 mmol). Complex 2 f (68 mg,
0.043 mmol,48%) was produced as an orange-red solid. M.p. 78 81 8C
(decomp); [a]2D4 À14.28 (c 2.6,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 7.74 (m,8H),7.63 7.29 (m,17H),7.24 7.18 (m,3H),7.10 7.06 (m,
General procedure for preparation of complex 2b (analogously 2a 2j):[36]
Ligand 1b (48.0 mg,0.143 mmol) and chloro-(1,5-cyclooctadiene)iridium( i)
dimer (48.2 mg,0.0717 mmol) were dissolved in CH 2Cl2 (3 mL) in a 10 mL
flask equipped with a condenser and a stir bar. The solution was refluxed
under N2 for 1 h. After the orange-red solution was cooled to room
temperature,NaBARF [18] (195 mg,0.22 mmol) was added followed by H 2O
(2 mL),and the resulting two-phase mixture was stirred vigorously for
15 min. The layers were separated and the aqueous layer was extracted with
CHCl3 (2 Â 10 mL). The combined organic extracts were washed with
water and evaporated. The residue was re-dissolved in EtOH (1.5 mL) and
crystallized by the slow addition of H2O to give 2b (133 mg,0.0887 mmol,
62%) as a yellow-orange solid. M.p. 162 1658C (decomp); [a]2D4 À54.28
(c 0.5,CDCl 3); 1H NMR (CDCl3,300 MHz): d 7.70 (m,8H),7.61 7.55
(m,10H),7.51 7.33 (m,2H),7.11 7.07 (m,2H),4.81 (m,1H),4.37 (m,
1H),4.27 4.18 (m,2H),4.04 (dd, J 9,3 Hz,1H),3.91 (m,1H),2.88 2.72
(m,3H),2.48 2.43 (m,1H),2.32 2.23 (m,2H),2.15 1.91 (m,4H),1.76
1.59 (m,2H),1.42 1.39 (m,1H),1.10 (s,9H); 13C NMR (CDCl3,75 MHz):
d 180.1,162.7,162.0,161.4,160.7,134.7,132.5,131.3,131.2 126.8,126.3,
122.7,119.1,117.5,94.8 (d, J 8 Hz),86.5 (d, J 17 Hz),72.5,67.8 (d, J
3 Hz),65.8,64.9,36.7 (d, J 5 Hz),33.6,30.1,28.6 (d, J 2 Hz),28.5,25.5
(d, J 3 Hz),23.8 (d, J 34 Hz); 31P NMR (CDCl3,121 MHz): d 7.48;
elemental analysis calcd (%) for C61H50BF24IrNOP: C 48.75,H 3.35,N 0.93;
found: C 48.80,H 3.39,N 0.87.
3H),6.48 6.46 (m,1H),5.43 (s,1H),4.86 (br,1H),4.65 (t,
J 9Hz,1H),
4.40 (m,1H),4.27 (m,1H),4.18 (m,1H),4.10 (m,1H),2.98 2.87 (m,2H),
2.80 2.50 (m,1H),2.57 2.45 (m,2H),2.39 2.17 (m,3H),1.96 1.70 (m,
3H),1.50 1.29 (m,2H); 31P NMR (CDCl3,121 MHz): d 9.9; elemental
analysis calcd (%) for C70H52BF24IrNOP H2O: C 51.54,H 3.34,N 0.86;
found: C 51.32,H 3.58,N 0.83.
Complex 2g: This compound was prepared by the same method used for
compound 2b,but beginning with 1g (55 mg,0.115 mmol) and chloro-(1,5-
cyclooctadiene)iridium(i) dimer (39 mg,0.058 mmol). Complex 2g (107 mg,
0.065 mmol,57%) was produced as an orange-red solid. M.p. 76 79 8C
(decomp); [a]2D4 À26.88 (c 3.0,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 7.80 7.10 (m,24H),6.57 (br,2H),5.65 (s,1H),4.98 (m,1H),4.64 (m,
2H),4.40 4.30 (m,1H),4.29 4.21 (m,1H),4.04 (br,1H),3.88 (br,1H),
3.11 2.82 (m,4H),2.50 (m,1H),2.42 2.34 (m,2H),2.21 2.14 (m,1H),
1.97 1.85 (m,3H),1.70 1.51 (br,3H),1.48 1.26 (m,2H);
31P NMR
(CDCl3,121 MHz): d 19.6 (br),11.7,0.4 (br); elemental analysis calcd
(%) for C72H56BF24IrNOP H2O: C 52.12,H 3.52,N 0.84; found: C 51.82,
H 3.42,N 0.91. The NMR spectra of this complex appear to be broadened
by a slow exchange mechanism.
Complex 2a: This compound was prepared by the same method used for
2b,but beginning with 1a (51 mg,0.17 mmol) and chloro-(15,-cycloocta-
Complex 2h: This compound was prepared by the same method used for
compound 2b,but beginning with 1h (80 mg,0.16 mmol) and chloro-(15, -
diene)iridium(i) dimer (58 mg,0.086 mmol). Complex
2a (136.5 mg,
0.094 mmol,55%) was produced as an orange solid. M.p. 138 141 8C
(decomp); [a]2D4 77.68 (c 0.5,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 7.78 7.21 (m,20H),7.13 7.06 (m,2H),4.88 (m,1H),4.38 4.20 (m,
2H),4.15 (m,1H),4.02 (dd, J 9,3 Hz,1H),3.90 (m,1H),2.94 2.69 (m,
3H),2.54 2.23 (m,4H),2.17 (s,3H),2.15 1.94 (m,2H),1.78 1.68 (m,
2H),1.59 1.46 (m,2H); 31P NMR (CDCl3,121 MHz): d 10.9; elemental
analysis calcd (%) for C58H44BF24IrNOP H2O: C 47.10,H 3.14,N 0.95;
found: C 46.98,H 2.98,N 1.04.
cyclooctadiene)iridium(i) dimer (55 mg,0.080 mmol). Complex
2h
(160 mg,0.097 mmol,60%) was produced as an orange-red solid. M.p.
173 1768C (decomp); [a]D24 À87.38 (c 2.6,CDCl ); 1H NMR (CDCl3,
3
300 MHz): d 8.01 7.10 (m,27H),6.77 (br,1H),6.52 (br,1H),6.09 (br,
1H),4.62 (br,1H),4.50 4.39 (2H),4.27 (1H),4.10 (1H),3.51 (1H),3.20
(m,2H),2.98 (3H),2.82 (3H),2.36 (2H),2.22 (m,5H),1.98 1.90 (m,2H),
1.72 (2H),1.58 (1H),1.36 1.25 (m,2H); 31P NMR (CDCl3,121 MHz): d
20.6 (br),11.1 (br), À0.4; elemental analysis calcd (%) for C73H58BF24Ir-
NOP: C 52.97,H 3.53,N 0.85; found: C 53.12,H 3.51,N 0.89. The NMR
spectra of this complex appear to be broadened by a slow exchange
mechanism.
Complex 2c: This compound was prepared by the same method used for
compound 2b,but beginning with 1c (68 mg,0.19 mmol) and chloro-(15, -
cyclooctadiene)iridium(i) dimer (63 mg,0.094 mmol). Complex 2c (196 mg,
0.128 mmol,68%) was produced as an orange solid. M.p. 169 171 8C
(decomp); [a]2D4 À16.38 (c 3.0,CDCl 3); 1H NMR (CDCl3,300 MHz):
d 8.05 (br,1H),7.74 (s,8H),7.55 (s,4H),7.50 7.20 (m,7H),4.79 (br,
1H),4.38 (m,2H),4.36 (m,1H),3.97 (m,2H),2.98 (br,3H),2.71 (br,1H),
2.48 (br,1H),2.26 (m,3H),2.22 1.88 (m,8H),1.53 (br,9H),1.50 1.25
Complex 2i: This compound was prepared by the same method used for
compound 2b,but beginning with 1i (54 mg,0.15 mmol) and chloro-15,-
cyclooctadiene)iridium(i) dimer (50 mg,0.075 mmol). Complex 2i (149 mg,
0.098 mmol,65%) was produced as an orange-yellow solid. M.p. 149
1518C (decomp); [a]D24 10.48 (c 3.0,CDCl 3); 1H NMR (CDCl3,
300 MHz): d 8.58 8.54 (m,2H),7.75 7.39 (m,23H),7.21 7.14 (m,
2H),4.85 (m,1H),4.65 4.55 (m,2H),4.30 4.24 (m,2H),3.76 (m,1H),
3.02 2.96 (m,1H),2.90 2.81 (m,2H),2.66 2.57 (m,1H),2.47 2.31 (m,
2H),2.24 2.18 (m,2H),2.04 1.99 (m,1H),1.89 1.59 (m,2H),1.59 1.49
(m,2H); 31P NMR (CDCl3,121 MHz): d 9.2; elemental analysis calcd
(%) for C63H46BF24IrNOP: C 49.68,H 3.04,N 0.92; found: C 49.69,H 3.15,
N 1.07.
(m,2H),1.07 (br,1H);
31P NMR (CDCl3,121 MHz): d 21.5 (br),11.5
(br),0.3; elemental analysis calcd (%) for C 63H54BF24IrNOP: C 49.42,H
3.55,N 0.91; found: C 49.69,H 3.68,N 1.00. The NMR spectra of this
complex appear to be broadened by a slow exchange mechanism.
Complex 2d: This compound was prepared by the same method used for
compound 2b,but beginning with 1d (42 mg,0.10 mmol) and chloro-(15, -
cyclooctadiene)iridium(i) dimer (34 mg,0.50 mmol). Complex 2d (69 mg,
Chem. Eur. J. 2001, 7,No. 24
¹ WILEY-VCH Verlag GmbH,D-69451 Weinheim,2001
0947-6539/01/0724-5399 $ 17.50+.50/0
5399